Business Context and Reporting Period
This Form 8-K was filed by Klotho Neurosciences, Inc. (not Greenland Mines Ltd) on February 23, 2026, reporting events occurring on February 19, 2026. The company is an emerging growth company incorporated in Delaware with its principal executive offices in Charlotte, NC. The filing details a material definitive agreement regarding a private placement of securities.
Key Financial Metrics and Transaction Details
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or debt levels. The primary financial data relates to the specific securities transaction:
- Shares Issued: 34,551,939 shares of common stock.
- Price Per Share: $0.2243 (based on the Nasdaq official closing price for the prior five trading days).
- Warrants Issued: Warrants to purchase an equal number of shares (34,551,939) at an exercise price of $0.2243 per share.
- Warrant Term: Five years.
- Expected Closing: On or before March 15, 2026.
Material Changes
The material change reported is the entry into a Securities Purchase Agreement with 10 investors. This transaction will result in significant dilution to existing shareholders upon closing, as the company agreed to issue over 34.5 million new shares and corresponding warrants. The filing does not provide comparative financial data to assess changes in revenue or profitability versus prior periods.
Guidance, Outlook, and Risks
Management Commentary: The filing is a standard disclosure of the agreement terms and does not include forward-looking guidance, outlook statements, or management commentary on operational performance.
Risks and Contingencies:
- Exercise Restriction: The warrants cannot be exercised prior to stockholder approval.
- Price Adjustments: The exercise price is subject to adjustment for stock dividends, splits, or combinations.
- Closing Contingency: The transaction is expected to close by March 15, 2026, but the filing does not explicitly state conditions precedent other than the agreement terms.
Investor Verification Checklist
- Verify the exact closing date of the transaction (expected by March 15, 2026).
- Confirm the total gross proceeds once the transaction closes.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific use of proceeds and covenants.
- Monitor for the required stockholder vote to enable warrant exercise.
- Check subsequent filings for any changes to the closing date or transaction terms.